Bernard Sagaert, eTheRNA CEO
August 25, 2022 10:56 AM EDTUpdated 11:35 AM
People
Financing

Mod­er­na co-founder, ex-Bay­er CEO jump aboard Bel­gian RNA biotech, in­vest­ing in Se­ries B round

Paul Schloesser

Associate Editor

As mR­NA has tak­en a more promi­nent perch thanks to the Covid-19 pan­dem­ic, a Eu­ro­pean biotech has now land­ed two peo­ple to its board of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times